Results 51 to 60 of about 5,062,336 (201)

Effectiveness of Radioiodine Therapy for Graves' Hyperthyroidism: A Quality-of-Life Assessment

open access: yesCurrent Internal Medicine Research and Practice Surabaya Journal
Introduction: Graves' disease, an autoimmune disorder characterized by hyperthyroidism, is commonly managed through radioactive iodine therapy, antithyroid drugs, and thyroidectomy.
Machfud Fauzi   +3 more
doaj   +1 more source

RADIOIODINE THERAPY OF PAPILLARY THYROID CANCER, COMPLICATED BY A RADIAL MYELITIS. CLINICAL CASE

open access: yesАрхивъ внутренней медицины, 2018
Over the past decades, there has been an increase in the incidence of thyroid cancer in most countries, and the most common form of thyroid cancer is papillary thyroid cancer. Application of radioiodine therapy for papillary thyroid cancer depends on the
L. M. Farkhutdinova
doaj   +1 more source

Potential of the drug-regulation iodide uptake in patients for prevention of radioiodine-refractory papillary thyroid cancer

open access: yesКлиническая и экспериментальная тиреоидология, 2014
Objective To evaluate the efficacy and feasibility of retinoic acid derivatives and lithium salts for radioiodine-refractory prevention in patients with differentiated thyroid cancer during multistage radioiodine therapy.
Dmitriy Kirillovich Fomin   +3 more
doaj   +1 more source

177Lu-DOTATATE and 177Lu-prostate-specific membrane antigen therapy in a patient with advanced metastatic radioiodine-refractory differentiated thyroid cancer after failure of tyrosine kinase inhibitors treatment

open access: yesWorld Journal of Nuclear Medicine, 2019
Patients with radioiodine-refractory differentiated thyroid cancer (RrDTC) have only a limited or no benefit from radioiodine therapy. For these patients, tyrosine kinase inhibitors have demonstrated encouraging results in advanced RrDTC.
M. Assadi, H. Ahmadzadehfar
semanticscholar   +1 more source

Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults [PDF]

open access: yesEndocrinology and Metabolism, 2016
BackgroundRadioactive iodine as a treatment modality has been shown in several studies to be a safe and effective therapy for Graves disease. However, there is still no uniformity regarding optimal dosing method.
Abigail U. Canto   +4 more
doaj   +1 more source

Follow-up of patients treated with retinoic acid for the control of radioiodine non-responsive advanced thyroid carcinoma

open access: yesBrazilian Journal of Medical and Biological Research, 2011
During thyroid tumor progression, cellular de-differentiation may occur and it is commonly accompanied by metastatic spread and loss of iodine uptake.
S.M. Coelho   +5 more
doaj   +3 more sources

SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I.

open access: yesPLoS ONE, 2012
Oncolytic adenoviruses can be engineered for better tumor selectivity, gene delivery and be armed for imaging and concentrating radionuclides into tumors for synergistic oncolysis.
Maria Rajecki   +9 more
doaj   +1 more source

Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells

open access: yesBreast Cancer, 2015
Radiosensitization using either metformin or 2-deoxy-d-glucose (2-DG) in various cancer cells has been reported. The present study reveals novel information on combining these drugs to enhance radiosensitization effect in breast cancer (BC) cells ...
Sushmita Chatterjee   +2 more
semanticscholar   +1 more source

Neonatal Thyrotoxicosis in Infants of Mothers with Graves’ Disease Treated for Radioiodine-Induced Hypothyroidism: A Literature Review

open access: yesChildren
Fetal and neonatal thyrotoxicosis occurs in up to 5% of pregnancies in mothers with Graves’ disease (GD). This condition is caused by stimulating antibodies against the thyrotropin receptor (TRAbs) that cross the placenta and may stimulate the fetal ...
Lucia Jankovski   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy